The median effective dose of oxycodone for postoperative analgesia in women underwent hysterectomy or myomectomy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024038

Enrollment

Unknown

Registered

2019-06-23

Start date

2019-06-21

Completion date

Unknown

Last updated

2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hysterectomy/myomectomy

Interventions

Different doses groups:iv. oxycodone difference doses

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: ASA (American Society of Anesthesiologists) physical status I to III; aged over 18 years; BMI between 20-30kg/m2; underwent elective hysterectomy or myomectomy surgery

Exclusion criteria

Exclusion criteria: With history of chronic pain; allergy or hypersensitivity to oxycodone or other ingredients in the formulations; unwilling or unable to give consent; patient refusal;the duration of operation exceed 120 minutes; with motion sickness and take analgesic or antiemetic before surgery; with significant liver/kidney impairment or severe respiratory disease.

Design outcomes

Primary

Measure	Time frame
NRS;	—

Secondary

Measure	Time frame
Prince-Henry score;patient satisfaction;NBP;HR;SPO2;	—

Countries

China

Contacts

Public ContactXiuying Wu

Shengjing Hospital of China Medical University

wuxiuying0415@163.com+86 18940251520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026